Canine pulmonary vasoreactivity to serotonin: role of protein kinase C and tyrosine kinase

Am J Physiol. 1997 Feb;272(2 Pt 2):H740-7. doi: 10.1152/ajpheart.1997.272.2.H740.

Abstract

The role of protein kinase C- and protein tyrosine kinase-mediated signal transduction in the canine pulmonary vascular response to serotonin (5-HT) was determined in the isolated blood-perfused dog lung. Pulmonary vascular resistances and compliances were measured with vascular occlusion techniques. 5-HT (10(-5) M) significantly increased precapillary resistance by approximately 150% and postcapillary resistance twofold and significantly decreased total vascular compliance to approximately 50% of control values by decreasing large-vessel compliance and middle-compartment compliance. The 5-HT2-receptor blocker ketanserin (10(-7) M), the protein kinase C inhibitor staurosporine (10(-7) M), the voltage-dependent Ca2+-channel blocker verapamil (10(-5) M), and the specific protein tyrosine kinase inhibitors genistein (5 x 10(-4) M) and tyrphostin 25 (5 x 10(-4) M) completely inhibited the pressor response to 5-HT, whereas the 5-HT1-receptor antagonist (-)pindolol (10(-7) M) had no significant effect on the serotonergic response. These results indicate that the canine pulmonary vascular response to 5-HT involves activation of 5-HT2 receptors and suggests that this receptor signal transduction pathway involves protein kinase C and tyrosine kinase and the activation of voltage-dependent Ca2+ channels.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology
  • Dogs
  • Enzyme Inhibitors / pharmacology
  • Female
  • In Vitro Techniques
  • Male
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / physiology*
  • Pulmonary Circulation / drug effects*
  • Serotonin / pharmacology*
  • Serotonin Antagonists / pharmacology
  • Vascular Resistance / drug effects
  • Vasomotor System / drug effects*
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • Serotonin Antagonists
  • Serotonin
  • Verapamil
  • Protein-Tyrosine Kinases
  • Protein Kinase C